Skip to content

Clinical trials

Phase 1/2 Endometrial Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 1/2 Country / region: France Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20141
20164
20181
20192
20205
20213
20233
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Completed4
Active, not recruiting3
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Inc.2
Eli Lilly and Company2
Novartis Pharmaceuticals2
Regeneron Pharmaceuticals2
Arno Therapeutics1
Artios Pharma Ltd1
Bolt Biotherapeutics, Inc.1
Centre Leon Berard1
Daiichi Sankyo1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms22
Ovarian Neoplasms12
Colorectal Neoplasms10
Neoplasms8
Carcinoma, Non-Small-Cell Lung6
Breast Neoplasms5
Biliary Tract Neoplasms4
Head and Neck Neoplasms4
Neoplasms by Site4
Stomach Neoplasms4

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.